Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Saunders

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusionsV M Macaulay, K J O'Byrne, M P Saunders, et al.
British Journal of Cancer|July 17, 1998
Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancerK J O'Byrne, M I Koukourakis, M P Saunders, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1997
A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tractJ P Braybrooke, K J O'Byrne, M P Saunders, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal, and immunological effectsD J Propper, M P Saunders, A J Salisbury, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
A phase II study of the modulation of 5-fluorouracil and folinic acid with high-dose infusional hydroxyurea in metastatic colorectal carcinomaK J O'Byrne, P A Philip, D J Propper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 31, 2011
A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancerN Starling, F Vázquez-Mazón, D Cunningham, et al.
ESMO Open|September 21, 2021
Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I studyR Bordonaro, A Calvo, A Auriemma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 20, 2016
Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM studyG Folprecht, C Pericay, M P Saunders, et al.
British Journal of Cancer|October 2, 2003
Modified de Gramont with oxaliplatin in the first-line treatment of advanced colorectal cancerM S Braun, F Adab, C Bradley, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2019
Novel phase I trial design to evaluate the addition of cediranib or selumetinib to preoperative chemoradiotherapy for locally advanced rectal cancer: the DREAMtherapy trialF E Marti Marti, G C Jayson, P Manoharan, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 1999
Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusionsV M Macaulay, K J O'Byrne, M P Saunders, et al.
British Journal of Cancer|July 17, 1998
Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancerK J O'Byrne, M I Koukourakis, M P Saunders, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1997
A phase II study of mitomycin C and oral etoposide for advanced adenocarcinoma of the upper gastrointestinal tractJ P Braybrooke, K J O'Byrne, M P Saunders, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal, and immunological effectsD J Propper, M P Saunders, A J Salisbury, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 6, 1999
A phase II study of the modulation of 5-fluorouracil and folinic acid with high-dose infusional hydroxyurea in metastatic colorectal carcinomaK J O'Byrne, P A Philip, D J Propper, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 31, 2011
A phase I study of sunitinib in combination with FOLFIRI in patients with untreated metastatic colorectal cancerN Starling, F Vázquez-Mazón, D Cunningham, et al.
ESMO Open|September 21, 2021
Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer: a dose-expansion, phase I studyR Bordonaro, A Calvo, A Auriemma, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 20, 2016
Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: the AFFIRM studyG Folprecht, C Pericay, M P Saunders, et al.
British Journal of Cancer|October 2, 2003
Modified de Gramont with oxaliplatin in the first-line treatment of advanced colorectal cancerM S Braun, F Adab, C Bradley, et al.
European Journal of Cancer (Oxford, England : 1990)|June 24, 2019
Novel phase I trial design to evaluate the addition of cediranib or selumetinib to preoperative chemoradiotherapy for locally advanced rectal cancer: the DREAMtherapy trialF E Marti Marti, G C Jayson, P Manoharan, et al.
Pageof 6